Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
166.84
+7.84 (4.93%)
At close: Dec 18, 2025, 4:00 PM EST
166.84
0.00 (0.00%)
After-hours: Dec 18, 2025, 5:45 PM EST
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts that cover Nutex Health stock have a consensus rating of "Strong Buy" and an average price target of $252.5, which forecasts a 51.34% increase in the stock price over the next year. The lowest target is $205 and the highest is $300.
Price Target: $252.5 (+51.34%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2025.
Analyst Ratings
The average analyst rating for Nutex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $225 → $205 | Strong Buy | Maintains | $225 → $205 | +22.87% | Aug 26, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $300 | Strong Buy | Reiterates | $300 | +79.81% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $225 | Strong Buy | Maintains | $100 → $225 | +34.86% | May 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +79.81% | May 15, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $60 → $150 | Strong Buy | Maintains | $60 → $150 | -10.09% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
980.80M
from 479.95M
Increased by 104.36%
Revenue Next Year
1.02B
from 980.80M
Increased by 4.10%
EPS This Year
15.37
from 9.69
Increased by 58.59%
EPS Next Year
12.50
from 15.37
Decreased by -18.68%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.0B | 1.1B | |
| Avg | 980.8M | 1.0B | |
| Low | 912.8M | 973.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 116.3% | 8.8% | |
| Avg | 104.4% | 4.1% | |
| Low | 90.2% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 15.82 | 20.54 | |
| Avg | 15.37 | 12.50 | |
| Low | 14.77 | 4.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 63.3% | 33.6% | |
| Avg | 58.6% | -18.7% | |
| Low | 52.4% | -68.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.